Maoli Wang

Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction.

Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction.

Journal: Scientific reports

Published: February 20, 2024

Chemotherapy is of prognostic significance to metaplastic breast cancer.

Chemotherapy is of prognostic significance to metaplastic breast cancer.

Journal: Scientific reports

Published: July 02, 2023

The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2- Breast Cancer.

The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2- Breast Cancer.

Journal: Advances in therapy

Published: January 18, 2023

CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.

CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.

Journal: International journal of analytical chemistry

Published: February 17, 2022

An Innovative Breast-Conserving Oncoplastic Technique for Treating Small to Medium Volume Breasts With a Tumor in the Lower Quadrant: The Folding Flap Technique.

An Innovative Breast-Conserving Oncoplastic Technique for Treating Small to Medium Volume Breasts With a Tumor in the Lower Quadrant: The Folding Flap Technique.

Journal: Frontiers in oncology

Published: December 22, 2021

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer.

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer.

Journal: Journal of oncology

Published: October 29, 2021

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.

Journal: Frontiers in immunology

Published: July 29, 2021

ASO Author Reflections: Breast-Conserving Surgery Could be Performed Safely in Well-Selected T1-T2 Centrally Located Breast Cancer.

ASO Author Reflections: Breast-Conserving Surgery Could be Performed Safely in Well-Selected T1-T2 Centrally Located Breast Cancer.

Journal: Annals of surgical oncology

Published: June 26, 2020

Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer.

Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer.

Journal: Annals of surgical oncology

Published: March 25, 2020

The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.

The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.

Journal: Annals of translational medicine

Published: November 09, 2019

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.

Journal: Bioscience reports

Published: September 15, 2019

Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.

Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.

Journal: Theranostics

Published: May 08, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026